Skip to content

Clinical Research

Dickerson

Research Description/Biography
Dr. Roland N. Dickerson’s research is practice-based and focused upon the metabolic support of the critically ill patient who requires parenteral or enteral nutrition therapy. As a Clinical Pharmacist in Nutrition Support and Clinical Coordinator of the Nutrition Support Service at Regional One Health (formerly Regional Medical Center at Memphis or The MED), pharmaceutical care as part of overall care is provided to approximately 15 to 20 patients daily. The majority of the patients are located in the Presley Memorial Trauma Center, the Memphis Firefighters Burn Center, or the general intensive care unit (surgical, trauma, neurosurgical, and medical patients). It is from this population where his practice-changing research initiatives are conducted. Specific areas of research include nutrient requirements across disease states, fluid and electrolyte therapy, glycemic control, vitamins, trace elements, drug-nutrient interactions, and pharmacotherapy designed to enhance nutrition tolerance and efficacy. Dr. Dickerson is a board certified nutrition support pharmacist who has practiced in the field for 35 years. He is a fellow of the American College of Clinical Pharmacy, American College of Critical Care Medicine, American Society of Health-System Pharmacists, and American Society for Parenteral and Enteral Nutrition. Dickerson is the author of over 180 peer-reviewed publications and book chapters and has delivered over 200 invited presentations internationally and across the United States. He is the first pharmacist awardee of the American Society for Parenteral and Enteral Nutrition (ASPEN)’s highest honor, the Jonathan Rhoads Research Lecture Award (2012) and recipient of the John M. Kinney International Award in Nutrition for the best clinical paper published in the journal Nutrition from 2008-2009 (2010). Dr. Dickerson also has been awarded the American Society of Health-Systems Pharmacists Sustained Contributions to the Literature Award (2009), American College of Clinical Pharmacy Clinical Practice Award (2015), and is the recipient of ASPEN’s Excellence in Nutrition Support Education Award (2016).
Projects

Current ongoing (as of 2017 -18) and planned future projects (2018 - ) include:

  • Vitamin D metabolism and cholecalciferol therapy during critical illness
  • Use of neural networks for predicting nitrogen requirements during critical illness
  • Factors influencing augmented renal clearance following traumatic injury
  • Impact of neuromuscular blockers upon gastric feeding tolerance
  • Clinical utility of the NUTRIC score for critically ill patients with traumatic injuries
  • Predictability of admission glycosylated hemoglobin concentration in diabetics for assessing glycemic instability following initiation of nutrition therapy
  • Nitrogen balance as a predictive marker for clinical outcomes in critically ill patients
Members and Collaborators

Roland N. Dickerson, PharmD
Joe Swanson, PharmD
Gayle Minard, MD
George O. Maish, III MD
Martin A. Croce, MD

Selected Publications

Original research publications from the past 5 years (2012-17):

  1. Dickerson RN, Pitts SL, Maish GO 3rd, Schroeppel TJ, Magnotti LJ, Croce MA, Minard G, Brown RO.     A reappraisal of nitrogen requirements for patients with critical illness and trauma. Journal of Trauma and Acute Care Surgery.2012;73(3):549-557.
  2. Dickerson RN, Johnson JL, Maish GO 3rd, Minard G, Brown RO. Evaluation of nursing adherence to a paper-based graduated continuous intravenous regular human insulin infusion algorithm. Nutrition.2012;28(10):1008-1011.
  3. Dickerson RN, Medling TL, Smith AC, Maish GO 3rd, Croce MA, Minard G, Brown RO. Hypocaloric, high-protein nutrition therapy in older vs younger critically ill patients with obesity. JPEN Journal of Parenteral and Enteral Nutrition.2013;37(3):342-351.
  4. Dickerson RN, Maish GO 3rd, Weinberg JA, Croce MA, Minard G, Brown RO. Safety and efficacy of intravenous hypotonic 0.225% sodium chloride infusion for the treatment of hypernatremia in critically ill patients. Nutrition in Clinical Practice.2013;28(3):400-408.
  5. Dickerson RN, Wilson VC, Maish GO 3rd, Croce MA, Minard G, Brown RO. Transitional NPH insulin therapy for critically ill patients receiving continuous enteral nutrition and intravenous regular human insulin. JPEN Journal of Parenteral and Enteral Nutrition.2013;37(4):506-516.
  6. Dickerson RN, Lynch AM, Maish GO 3rd, Croce MA, Minard G, Brown RO. Improved safety with intravenous insulin therapy for critically ill patients with renal failure. Nutrition.2014;30(5):557-562.
  7. Dickerson RN, Maish GO 3rd, Croce MA, Minard G, Brown RO. Influence of aging on nitrogen accretion during critical illness. JPEN Journal of Parenteral and Enteral Nutrition.2015;39(3):282-290.
  8. Dickerson RN, Berry SC, Ziebarth JD, Swanson JM, Maish GO 3rd, Minard G, Brown RO. Dose response effect of ergocalciferol therapy on serum 25-hydroxyvitamin D concentration during critical illness. Nutrition.2015;31(10):1219-1223.
  9. Dickerson RN, Voss JR, Schroeppel TJ, Maish GO 3rd, Magnotti LJ, Minard G, Croce MA. Feasibility of jejunal enteral nutrition for patients with severe duodenal injuries. Nutrition.2016;32(3):309-314.
  10. Dickerson RN, Van Cleve JR, Swanson JM, Maish GO 3rd, Minard G, Croce MA, Brown RO. Vitamin D deficiency in critically ill patients with traumatic injuries. Burns & Trauma.2016;4:28
  11. Cogle SV, Smith SE, Maish GO 3rd, Minard G, Croce MA, Dickerson RN. Sliding scale regular human insulin for identifying critically ill trauma patients who require intensive insulin therapy and for glycemic control in those with mild to moderate hyperglycemia. Journal of Pharmacy and Nutrition Sciences. 2017;7(3):106-115.
  12. Johnston CT, Maish GO 3rd, Minard G, Croce MA, Dickerson RN. Evaluation of an intravenous potassium dosing algorithm for hypokalemic critically ill patients. JPEN Journal of Parenteral and Enteral Nutrition.2017;41(5):796-804.

 

Hamilton

Projects
  • Stress Ulcer Prophylaxis in Critically Ill Patients
  • Use of social media and online learning in pharmacy education
Selected Publications
  1. Horner D, Altshuler D, Droege C, Feih J, Ferguson K, Fiorenza M, Greathouse K, Hamilton LA, Pfaff C, Roller L, Stollings J, Wong A. Major publications in the critical care pharmacotherapy literature: January – December 2016; J Crit Care 2017: In press.
  2. Livesay S, Figueroa SA, Hamilton LA, Cahoon WD Jr., Blissitt PA. Clinical Q&A: Translating Therapeutic Temperature Management from Theory to Practice. Ther Hypothermia Temp Manag 2017; 7: 178-82.
  3. Hamilton LA, Darby SH, Hamilton AJ, Wilkerson MH, Morgan KA. Case Report of Wernicke’s Encephalopathy After Sleeve Gastrectomy.  Nutr Clin Pract 2017: In press.
  4. Bader MK, Cahoon WD Jr., Figueroa SA, Wavra T, Guanci MM, Mathiesen C, Hamilton LA. Clinical Q&A: Translating Therapeutic Temperature Management from Theory to Practice. Ther Hypothermia Temp Manag 2017; 7: 111-115. 
  5. Hamilton LA, Collins-Yoder A, Collins RE. DILI: Drug Induced Liver Injury. AACN Adv Crit Care 2016; 27: 430-40.
  6. Rowe AS, Mahbubani PS, Bucklin MH, Clark CT, Hamilton LA. Activated Prothrombin Complex Concentrate Versus Plasma for Reversal of Warfarin-Associated Hemorrhage. Pharmacotherapy 2016; 36: 1132-7.
  7. Hamilton LA, Franks A, Heidel RE, McDonough SLK, Suda KJ. Assessing the Utility of Online Learning and Social Media in Pharmacy Education.  Am J Pharm Educ 2016; 80: Article 97.
  8. Madere TC, Mendez JB, Nordmeyer ST, Heidel RE, Hamilton LA. Evaluation of Intravenous Acetaminophen on Length of Stay in Abdominal Surgery Patients.  Hosp Pharm 2016; 51: 230-6.

 

Hudson

Biography

Dr Hudson is Professor in the Department of Clinical Pharmacy and Translational Science and the Department of Medicine (Division of Nephrology) at the University of Tennessee Health Science Center in Memphis.

Dr. Hudson received a B.A. in chemistry from the University of Virginia in 1992, a Doctor of Pharmacy from Virginia Commonwealth University-Medical College of Virginia (VCU/MCV) in 1996, and completed a 2-year Nephrology fellowship at VCU-MCV in 1998. She joined the faculty at the University of Tennessee in 1998 where her teaching activities for students, residents and fellows focus in nephrology. Dr Hudson’s research interests include drug disposition in the chronic kidney disease population and during renal replacement therapy and management of secondary complications in patients with end-stage renal disease. She also maintains her practice as a Clinical Pharmacist specializing in Nephrology at Methodist University Hospital in Memphis and is a consultant for outpatient dialysis units.

Dr Hudson is President of the National Kidney Foundation (NKF) serving West TN and an active member of pharmacy and nephrology related organizations. She is currently serving a 3-year term as Secretary of the American College of Clinical Pharmacy (ACCP) Board of Directors. She was a member of the programming committee for the American Society of Nephrology Kidney Week 2016 and is currently serving as a member of the NKF Spring Clinical Meetings Program Committee. She has been recognized as a Fellow of the American Society of Nephrology, ACCP and the NKF. She also serves as a reviewer for the professional journals including the American Journal of Kidney Disease, Kidney International, and Pharmacotherapy.

Projects

Recent and Ongoing Projects:

  • ASHP Foundation Grant 2017-2019

– Clinical Pharmacy Interventions to Improve Transitions of Care and Reduce Hospital Readmissions in End-Stage Renal Disease Patients with Heart Failure and Infection

– Role: Principal Investigator

– Goal: To provide evidence that implementation of a pharmacist-led medication evaluation and transitions of care program for ESRD patients who have heart failure or infections is a valuable addition to improve patient outcomes and reduce health care costs.

  • Oxnard Foundation Grant 2014-2016

– Development of Antibiotic Dosing Recommendations for Sustained Low Efficiency Dialysis.

– Role: Principal Investigator

– Goal: To quantify the removal of the antibiotics cefepime, meropenem, pipericillin/tazobactam, daptomycin, and vancomycin by sustained low efficiency dialysis (SLED) by conducting a pharmacokinetic study in patients undergoing SLED in the critical care setting and to develop dosing recommendations for these antibiotics in patients requiring SLED.

  • University of Tennessee College of Pharmacy Faculty Seed Grant Award 2012-2014

– Pharmacokinetics of Imipenem/Cilastatin in Burn Patients Undergoing a Novel High-Volume Hemofiltration Therapy.

– Role: Co-Investigator

– Goal: To quantify the systemic and extracorporeal clearance of imipenem and cilastatin in burn patients receiving high volume hemofiltration.

Selected Publications
  1. Feng C, Hu ZY, Laizure SC, Hudson JQ. Simple and sensitive assay for simultaneous quantification of six antibiotics in human plasma using liquid chromatography-tandem mass spectrometry: formic acid plays an important role. Bioanalysis 2017;9(5):469-483.  
  2. Schaapveld-Davis CM, Negrete AL, Hudson JQ, Saikumar J, Finch CK, Kocak M, Hu P, Van Berkel MA. End-Stage Renal Disease Increases Rates of Adverse Glucose Events When Treating Diabetic Ketoacidosis or Hyperosmolar Hyperglycemic State. Clin Diabetes 2017 May 3; doi:10.2337/cd 16-0060.  
  3. Alabdan N, Gosmanova EO, Tran NQT, Oliphant CS, Pan H, Broyles JE, Hudson JQ. Risk Factors for Acute Kidney Injury in Patients Continued on Renin-Angiotensin System Blockers During Hospitalization. Accepted for publication in the Am J Med Sci 2016.
  4. Boucher BA, Hudson JQ, Hill DM, Swanson JM, Wood GC, Laizure C, Arnold-Ross A, Hu Z, Hickerson WL. Pharmacokinetics of Imipenem/Cilastatin in Burn Intensive Care Unit Patients Undergoing High-Dose Continuous Venovenous Hemofiltration. Pharmacotherapy 2016;36(12):1229-1237.
  5. Hudson JQ*, Bean JR, Burger CF, Stephens AK, McFarland MS. Comparison of the CKD-EPI, MDRD, and CG Equations for Drug Dosing in the Elderly Population. Int J Clin Pract 2015;69(3):313-320.
  6. Hudson JQ*, Siddiqui O. Accuracy of Urine Collection Methods Compared to Measured GFR in Adults with Liver Disease. Transplant Proc 2014;46:3487-3491.
  7. Harris LE, Reaves AB, Krauss AG, Griner J, Hudson JQ.  Evaluation of Antibiotic Prescribing Patterns in Patients Receiving Sustained Low-Efficiency Dialysis. Int J Pharm Pract [published online: 9 JUL 2012 | DOI: 10.1111/j.2042-7174.2012.00226.x].
  8. Pinner NA, Canada RB, Broyles JE, Hudson JQ. Evaluation of Vancomycin and Gentamicin Dialysis Clearance Using In Vivo and In Vitro Systems. Ren Fail 2012;34:703-707.
  9. McFarland MS, Markley BM, Zhang P, Hudson JQ. Evaluation of Modification of Diet in Renal Disease study and Cockcroft-Gault equations for sitagliptin dosing. J Nephrol 2012; 25(4):515-522.
  10. Hudson JQ, Nyman HA. Use of estimated glomerular filtration rate for drug dosing in the chronic kidney disease patient. Curr Opin Nephrol Hypertens. 2011 Sep;20(5):482-91.
  11. Hudson JQ, Mason DL, Huch KM.  Estimates of Kidney Function in Obese African-Americans with Chronic Kidney Disease. Nephron Clin Pract 2011;118:c101-c108.
  12. Hudson JQ, McNeely EB, Green CA, Jennings LK. Assessment of Eptifibatide Clearance by Hemodialysis Using an In Vitro System. Blood Purif 2010;30:266-271.
  13. Joy MS, Dehart RM, Gilmartin C, Hachey DM, Hudson JQ, Prucnicki M, Dumo P, Grabe DW, Saseen J, Zillich AJ. Clinical Pharmacists as Multidisciplinary Health Care Providers in the Management of Chronic Kidney Disease: A Joint Opinion by the Nephrology and Ambulatory Care Practice and Research Networks of the American College of Clinical Pharmacy.  Am J Kidney Dis 2005;45:1105-1118.
  14. Zillich AJ, Saseen JJ, DeHart RM, Dumo P, Grabe DW, Gilmartin C, Hachey DM, Hudson JQ, Pruchnicki MC, Joy MS. Caring for Patients with Chronic Kidney Disease:  A Joint Opinion of the Ambulatory Care and Nephrology Practice and Research Networks of the American College of Clinical Pharmacy. Pharmacotherapy 2005:24(1):123-43.
  15. Hudson JQ, Comstock TJ, Feldman GM. Evaluation of an in vitro dialysis system to predict drug removal. Nephrol Dial Transplant 2004;19:400-405.
  16. Hudson JQ. Drug disposition in patients receiving continuous renal replacement therapies. J Pediatr Pharmacol Ther 2001;6:15-39.

 

Wheeler

Description
My research is focused on everyday issues affecting pharmacy practitioners and other healthcare professionals including projects focused on: workforce development, medication safety, continuing professional development, and the scholarship of teaching and learning.
Members and Collaboration
I have collaborated with a number of UT faculty and students on all 3 campuses. In addition, through the American Association of Colleges of Pharmacy (AACP), I have been able to collaborate with pharmacy faculty across the nation.
Projects

Currently, Drs. Hohmeier, Renfro, Wang, and I are completing a three-phase pharmacy technician workforce study sponsored by PTCB.  We are analyzing roles and responsibilities of pharmacy technicians and exploring workflow models that allow pharmacies to pursue increasing clinical services.

Alec Sain (P3), Dviti Mody (P3), and I are partnering with the Shade Tree Clinic, a clinic run by Vanderbilt medical students, on a scholarship of teaching and learning project titled “Assessing the impact of an educational enhanced podcast series focused on the dispensing of high alert diabetic medications on student performance and confidence in a student run free clinic.
Selected Publications
  1. Wheeler, JS, Ngo, T, Cecil, J, Borja-Hart, N. Exploring employer job requirements: An analysis of pharmacy job announcements. J Am Pharm Assoc (2003), 2017. 57(6): 723-28.
  2. Wheeler, JS, Duncan, R, Hohmeier, K. Medication Errors and Trainees: Advice for Learners and Organizations. Ann Pharmacother, 1060028017725092, 2017.
  3. Wheeler JS, McDonough SLK, Hagemann, TM. Assessing self-assessment practices: A survey of U.S. colleges and schools of pharmacy. Currents in Pharmacy Teaching and Learning, 2017.
  4. Wheeler, JS, Borja-Hart, N, Hagemann, TM. Key Questions to Ask When Establishing a Clinical Practice: What I Wish I Knew When I Started. Hosp Pharm, 51 (9), 699-702, 2016.
  5. Liang, B, Wheeler, JS, Blanchette, LM. Impact of Combination Antibiogram and Related Education on Inpatient Fluoroquinolone Prescribing Patterns for Patients With Health Care-Associated Pneumonia. Ann Pharmacother, 50 (3), 172-9, 2016.
  6. Wheeler, JS, Ray, SM, Helmer, RS, Stevens, AB, Franks, AS. Development and implementation of an interdisciplinary pulmonary care clinic within an existing clinic program. Am J Health Syst Pharm, 72 (21), 1844-7, 2015.
  7. Wheeler J, Ducker ML. Pneumococcal vaccination in older adults: An update for pharmacists. US Pharm, 7 (40), 54-56, 2015.
  8. Barrons R, Wheeler J, Woods JA. Opportunities for inhaler device selection in elderly patients with asthma or COPD. Patient Intelligence., 7, 63-75, 2015.
  9. Woods JA, Wheeler J, Finch CK, Pinner N. Corticosteroids in the treatment of acute exacerbations of chronic obstructive pulmonary disease. International Journal of Chronic Obstructive Pulmonary Disease, 9 (May), 421-30, 2014.
  10. Ray SM, Wheeler J, Byrd D. A longitudinal learning experience to prepare residents for a career in academia. Currents in Pharmacy Teaching and Learning, 5 (6), 645-65, 2013.

 

Wood

Description
Dr. Wood’s research primarily focuses on improving the management of hospital-acquired infections in critically ill trauma patients.  Research areas have included the treatment of highly-resistant Gram-negative infections, use of aerosolized antibiotics in ventilator-associated pneumonia (VAP), improving the diagnosis of VAP, optimal duration of therapy for various infections (VAP, bacteremia, UTI), pharmacokinetics and pulmonary penetration of antibiotics, and genomic risk for VAP.  He also occasionally publishes on the improving the management of traumatic brain injury and acute spinal cord injury.
Members and Collaborators
Primary College of Pharmacy faculty collaborators: Joseph M. Swanson, PharmD, and Bradley A. Boucher, PharmD.
Selected Publications
  1. Boucher BA, Hudson JQ, Hill DM, Swanson JM, Wood GC, Laizure SC, Arnold-Ross A, Hu ZY, Hickerson WL.  Pharmacokinetics of imipenem/cilastatin in burn intensive care unit patients undergoing high dose continuous venovenous hemofiltration.  Pharmacother 2016;36:1229-37. 
  2. Jarrell AS, Wood GC, Ponnapula S, Magnotti LJ, Croce MA, Swanson JM, Boucher BA, Fabian TC.  Short duration treatment for catheter-associated urinary tract infections in critically ill trauma patients.  J Trauma Acute Care Surg 2015;79:649-53.  (Project Director, Corresponding Author)
  3. Wood GC, Kimborowicz K, Boucher BA, Croce MA, Kuhl DA, Kelley CA, Chambers M, Swanson JM, Freire AX, Fabian TC.  Short-term fluconazole therapy for the treatment of candiduria in critically ill patients.  Clin Med Insights: Trauma and Intensive Med 2015;6:19-23.
  4. McClellan N, Swanson JM, Magnotti LJ, Griffith TW, Wood GC, Croce MA, Boucher BA, Mueller EW, Fabian TC.  Adjunctive intraventricular antibiotic therapy for bacterial central nervous system infections in critically ill patients with traumatic brain injury.  Ann Pharmacother 2015;49:515-22.
  5. Wood GC, Boucher AB, Johnson JL, Wisniewski JN, Magnotti LJ, Croce MA, Swanson JM, Boucher BA, Fabian TC.  Effectiveness of pseudoephedrine as adjunctive therapy for neurogenic shock after acute spinal cord injury: A case series.   Pharmacother 2014;34:89-93. 
  6. Wells DL, Swanson JM, Wood GC, Magnotti LJ, Boucher BA, Croce MA, Harrison CG, Muhlbauer MS, Fabian TC.  The relationship between serum sodium and intracranial pressure when using hypertonic saline to target mild hypernatremia in patients with head trauma.  Crit Care 2012;16:R193. 
  7. Swanson JM, Wood GC, Xu L, Tang LE, Meibohm B, Homayouni R, Croce MA, Fabian TC.  Developing a gene expression model for predicting ventilator-associated pneumonia in trauma patients: A pilot study.  PLoS One 2012;7:e42065.  doi:10.1371/journal.pone.0042065 (Co-Primary Author, Grant PI) 
  8. Hamilton LA, Wood GC, Magnotti LJ, Croce MA, Martin JB, Swanson JM, Boucher BA, Fabian TC.  Treatment of methicillin-resistant Staphylococcus aureus ventilator-associated pneumonia with high-dose vancomycin or linezolid.  J Trauma Acute Care Surg 2012;72;1478-83. (Project Director) 
  9. Czosnowski QA, Wood GC, Magnotti LJ, Croce MA, Swanson JM, Boucher BA, Fabian TC.  Treatment and outcomes of Stenotrophomonas maltophilia ventilator-associated pneumonia.  Pharmacotherapy 2011;31:338-45.  (Project Director)
  10. Dager W, Bolesta S, Brophy G, Dell K, Gerlach A, Kirsteller J, Micek S, Hess M, Bentley M, Juang P, MacLaren R, Kane-Gill S, Haase K, Mann H, Miller C, Pepe D, Southwood R, Weant K, Rebuck J, Wood GC.  An opinion paper outlining recommendation for training, credentialing, documenting, and justifying critical care pharmacy services.  Pharmacotherapy 2011;31:135e-175e. 
  11. Le J, Ashley ED, Neuhauser MM, Brown J, Gentry C, Klepser ME, Marr AM, Schiller D, Schwiesow JN, Tice S, VandenBussche HL, Wood GC, SIDP Aerosolized Antimicrobials Task Force.  Consensus summary of aerosolized antimicrobial agents: Application of guideline criteria.  Pharmacotherapy 2010;30:562-84.  (VAP Subcommitee Chair for Task Force)
  12. Luyt CE, Clavel M, Guntupalli K, Johannigman J, Kennedy JI, Wood GC, Corkery K, Gribben D, Chastre J.  Pharmacokinetics and lung delivery of PDDS-aerosolized amikacin (NKTR-061) in intubated and mechanically ventilated patients with nosocomial pneumonia.  Critical Care 2009;13:R200.  (doi:10.1186/cc8206) 
  13. Czosnowski QA, Wood GC, Magnotti LJ, Croce MA, Swanson JM, Boucher BA, Fabian TC. Adjunctive aerosolized antibiotics for treating ventilator-associated pneumonia.  Pharmacotherapy 2009;29:1054-60.  (Project Director)
  14. Swanson JM, Wood GC, Croce MA, Mueller EW, Boucher BA, Fabian TC.  Utility of preliminary bronchoalvolar lavage results in suspected ventilator-associated pneumonia.  J Trauma 2008;65:1271-7.  (Project Director, Grant PI) 
  15. Mueller EW, Croce MA, Boucher BA, Hanes SD, Wood GC, Swanson JM, Chennault SK, Fabian TC.  Repeat bronchoalvolar lavage to guide antibiotic duration for ventilator-associated pneumonia.  J Trauma 2007;63:1329-37.
  16. Wood GC, Swanson JM.  Aerosolized antibiotics for the prevention and treatment of hospital-acquired pneumonia.  Drugs 2007;67:903-14. 
  17. Wood GC, Mueller EW, Croce MA, Boucher BA, Fabian TC.  Candida sp. isolated from bronchoalveolar lavage: clinical significance in critically ill trauma patients.  Intensive Care Med 2006;32:599-603. 
  18. Croce, MA, Fabian TC, Mueller EW, Maish GO, Cox JC, Bee TK, Boucher BA, Wood GC.  The appropriate diagnostic threshold for ventilator-associated pneumonia using quantitative cultures.  J Trauma 2004;56:931-936.  (Senior Author)
  19. Wood GC, Hanes SD, Boucher BA, Croce MA, Fabian TC.  Tetracyclines for treating ventilator-associated pneumonia caused by AcinetobacterIntensive Care Medicine 2003;29:2072-2076.
  20. Mueller EW, Wood GC, Kelley MS, Boucher BA, Fabian TC, Croce MA.  The predictive value of preliminary colony counts from bronchoalveolar lavage cultures in critically ill trauma patients.  American Surgeon 2003;69:749-756.  (Project Director)
  21. Wood GC, Boucher BA, Croce MA, Hanes SD, Herring VL, Fabian TC.  Aerosolized ceftazidime for the prevention of ventilator-associated pneumonia and its effects on the inflammatory response in critically ill trauma patients.  Pharmacotherapy 2002;22:972-82.  (Primary Author, Grant Co-PI)
  22. Hanes SC, Tolley EA, Demirkan K, Wood GC, Croce MA, Boucher BA.  Risk factors for late-onset nosocomial pneumonia caused by Stenotrophomonas maltophilia in critically ill trauma patients.  Clinical Infectious Diseases  2002;35:228-35. 
  23. Wood GC, Hanes SD, Croce MA, Fabian TC, Boucher BA.  Ampicillin-sulbactam compared to imipenem-cilastatin for the treatment of Acinetobacter ventilator-associated pneumonia.  Clinical Infectious Diseases 2002;34:1425-30.

Last Published: Nov 7, 2017